NYSE · CIK 0001388320
ATNM Actinium Pharmaceuticals, Inc.
Insider trading from SEC Form 4. Last filing 38 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at Actinium Pharmaceuticals, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 63 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Jeffrey W. Chell director | AGrant or award Common Stock | +61,600 | $0.00 | $0 | 61,600 | 38 d ago |
| Sep 2, 2026 | Richard I Steinhart director | AGrant or award Common Stock | +62,800 | $0.00 | $0 | 63,116 | 38 d ago |
| Sep 2, 2026 | Sandesh Seth Chief Executive Officer | AGrant or award Common Stock | +753,600 | $0.00 | $0 | 938,081 | 38 d ago |
| Sep 2, 2026 | C. David Nicholson director | AGrant or award Common Stock | +62,800 | $0.00 | $0 | 63,300 | 38 d ago |
| Sep 2, 2026 | June Sherie Almenoff director | AGrant or award Common Stock10b5-1 | +18,000 | $0.00 | $0 | 18,000 | 38 d ago |
| Sep 2, 2026 | Ajit Shetty director | AGrant or award Common Stock | +61,600 | $0.00 | $0 | 62,357 | 38 d ago |
| Sep 2, 2026 | Jeffrey W. Chell director | AGrant or award Stock Option (Right to Buy)derivative | +92,400 | $0.00 | $0 | 92,400 | 38 d ago |
| Sep 2, 2026 | C. David Nicholson director | AGrant or award Stock Option (Right to Buy)derivative | +94,200 | $0.00 | $0 | 94,200 | 38 d ago |
| Sep 2, 2026 | Ajit Shetty director | AGrant or award Stock Option (Right to Buy)derivative | +92,400 | $0.00 | $0 | 92,400 | 38 d ago |
| Sep 2, 2026 | June Sherie Almenoff director | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +27,000 | $0.00 | $0 | 27,000 | 38 d ago |
| Sep 2, 2026 | Sandesh Seth Chief Executive Officer | AGrant or award Common Stock | +1,027,274 | $0.00 | $0 | 1,965,355 | 38 d ago |
| Sep 2, 2026 | Richard I Steinhart director | AGrant or award Stock Option (Right to Buy)derivative | +94,200 | $0.00 | $0 | 94,200 | 38 d ago |
| Sep 2, 2026 | Sandesh Seth Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +1,130,400 | $0.00 | $0 | 1,130,400 | 38 d ago |
| Aug 18, 2025 | Sandesh Seth Chief Executive Officer | FTax withholding Common Stock | -120,900 | $1.71 | $207k | 184,481 | Aug 20, 2025 |
| Mar 31, 2025 | Richard I Steinhart director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Jeffrey W. Chell director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | June Sherie Almenoff director | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | C. David Nicholson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Ajit Shetty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Sandesh Seth Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,666 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Steve O'Loughlin Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Richard I Steinhart director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Sandesh Seth Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | C. David Nicholson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Jeffrey W. Chell director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Ajit Shetty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Steve O'Loughlin Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,666 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | C. David Nicholson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Richard I Steinhart director | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Sandesh Seth Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -33,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Steve O'Loughlin Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Jeffrey W. Chell director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Ajit Shetty director | DDisposition to issuer tock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | C. David Nicholson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Steve O'Loughlin Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,833 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Ajit Shetty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Jeffrey W. Chell director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Sandesh Seth Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Richard I Steinhart director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | C. David Nicholson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Jeffrey W. Chell director | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,351 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Richard I Steinhart director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Ajit Shetty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,351 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Steve O'Loughlin Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -13,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Sandesh Seth Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -139,062 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | C. David Nicholson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,351 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Richard I Steinhart director | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,351 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Ajit Shetty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -72,156 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Steve O'Loughlin Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -59,066 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Sandesh Seth Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -310,182 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Jeffrey W. Chell director | DDisposition to issuer Stock Option (Right to Buy)derivative | -72,156 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Sandesh Seth Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -827,366 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Steve O'Loughlin Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -107,463 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Jeffrey W. Chell director | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,311 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Ajit Shetty director | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,311 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Richard I Steinhart director | DDisposition to issuer Stock Option (Right to Buy)derivative | -72,156 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | C. David Nicholson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -72,156 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Richard I Steinhart director | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,311 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Steve O'Loughlin Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -256,438 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | C. David Nicholson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,311 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Sandesh Seth Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -984,367 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | Steve O'Loughlin Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -253,123 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Nov 1, 2024 | June Sherie Almenoff director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- June Sherie Almenoffdirector
- Jeffrey W. Chelldirector
- C. David Nicholsondirector
- Steve O'LoughlinChief Financial Officer
- Sandesh SethChief Executive Officer
- Ajit Shettydirector
- Richard I Steinhartcfo, officer, director
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.